New method pioneered to identify brain cancer patients most likely to benefit from immunotherapy
Monday, April 4, 2016 - 20:20
in Health & Medicine
A promising method has been developed to assess how changes in the immune response can help predict the effectiveness of a new immunotherapy in people with glioblastoma (GBM), the most common and deadly type of brain cancer.